Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-09
2008-09-02
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S146000, C548S148000, C548S152000, C548S153000, C548S154000, C514S365000, C514S367000
Reexamination Certificate
active
07419993
ABSTRACT:
The invention relates to triazolo-thiazole analogues of epothilone A and epothilone B.
REFERENCES:
patent: 6441186 (2002-08-01), Nicolaou et al.
patent: 6900160 (2005-05-01), Hoefle et al.
patent: 0 625 520 (1994-11-01), None
patent: WO 00/50423 (2000-08-01), None
Hoefle G. et al.: “N-Oxidation of Epothilone A. C- and O-Acyl Rearrangement to C-19 and C-21 Substituted Epothilones”;Angewandte Chemie. Weinheim, DE,; vol. 38, Jul. 1999, pp. 1971-1974.
Glaser Nicole
Hoefle Gerhard
Frommer & Lawrence & Haug LLP
Helmholtz Center of Infection Research GmbH
Santucci Ronald R.
Shameem Golam M
LandOfFree
Triazolo-epothilones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolo-epothilones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolo-epothilones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980302